Keryx Biopharmaceuticals, Inc. EBITDA Margin 2010-2018 | KERX
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Keryx Biopharmaceuticals, Inc. (KERX) over the last 10 years. The current EBITDA margin for Keryx Biopharmaceuticals, Inc. as of September 30, 2018 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2018-09-30 | $0.10B | $-0.09B | -89.47% |
| 2018-06-30 | $0.08B | $-0.10B | -118.29% |
| 2018-03-31 | $0.07B | $-0.04B | -54.93% |
| 2017-12-31 | $0.06B | $-0.04B | -63.93% |
| 2017-09-30 | $0.05B | $-0.04B | -80.77% |
| 2017-06-30 | $0.04B | $-0.06B | -139.53% |
| 2017-03-31 | $0.04B | $-0.10B | -281.08% |
| 2016-12-31 | $0.03B | $-0.09B | -275.00% |
| 2016-09-30 | $0.03B | $-0.07B | -242.86% |
| 2016-06-30 | $0.03B | $-0.06B | -219.23% |
| 2016-03-31 | $0.02B | $-0.08B | -395.00% |
| 2015-12-31 | $0.01B | $-0.10B | -714.29% |
| 2015-09-30 | $0.01B | $-0.13B | -1400.00% |
| 2015-06-30 | $0.01B | $-0.13B | -2600.00% |
| 2014-12-31 | $0.01B | $-0.11B | -1009.09% |
| 2009-12-31 | $0.03B | $0.01B | 36.00% |
